Clinical Trials
2 trialsNCT06180460 2025-10-08
CALM: Managing Distress in Malignant Brain Cancer
Virginia Commonwealth University
Phase NA Completed
NCT00827177 2014-01-24
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed